THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease

NCT01355120 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

171

Enrollment

OTHER

Sponsor class

Conditions

Ocular Melanoma

Interventions

DRUG: Ipilimumab

Sponsor

Prof. Dr. med. Dirk Schadendorf